Sales News

Stay updated with the latest sales news. Read about sales performance, revenue updates, market trends, and strategic sales initiatives across various industries. Discover how companies achieve their sales targets and drive growth.

Oct 7, 2026 at 6:00 AM

Triple Flag Announces Strong Revenue in Q3 2026 and First Deliveries from Ravenswood

TORONTO--(BUSINESS WIRE)--Triple Flag Precious Metals Corp. (with its subsidiaries, “Triple Flag” or the “Company”) (TSX: TFPM, NYSE: TFPM) announced revenue of US$106.7 million for the third quarter of 2026 from quarterly metal sales of 25,030 gold equivalent ounces (“GEOs”). All dollar amounts are expressed in US dollars, unless otherwise noted. “Our business achieved strong performance in the third quarter, including the first quarter of deliveries from the Ravenswood gold mine in Australia....
Oct 7, 2026 at 2:21 AM

Valerio Therapeutics Provides an Update on Its Business and Presents Its Financial Results for the First Half of 2026

VILLEJUIF, France--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics (FR0010095596 - ALVIO), a pioneering biotechnology company in the field of next-generation precision therapies (“Valerio”, or the “Company”), provides an update on its operations and presents its financial results for the half-year ended 30 June 2026. “The first half of 2026 marked a decisive milestone in the consolidation of our strategic refocusing and in the transformation of Valerio Therapeutics. The operational launc...
Oct 6, 2026 at 9:19 AM

bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company developing noninvasive healthcare solutions for the early detection and monitoring of lung disease, today announced that sales of its CyPath® Lung test for lung cancer increased more than 100% through the third quarter of 2026 compared to 2025, reflecting continued growth in clinical adoption of the Company’s noninvasive test for assessing the likelihood of lung cancer in high-risk indivi...
Oct 6, 2026 at 7:00 AM

ReposiTrak Touchless Retail™ Leads to 6% Sales Increase for National Dairy

SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak, Inc. (NYSE: TRAK), the leader in retail supply chain, merchandising, compliance and traceability solutions, today announced the launch of a Touchless Retail™ merchandising program in a large American retailer with a national footprint, working with a national dairy CPG supplier to provide supplemental in-store merchandising coverage.The dairy supplier already maintains its own merchandising workforce, but like many large CPG companies, it cannot alway...
Oct 6, 2026 at 3:30 AM

UMC Reports Sales for September 2026

TAIPEI, Taiwan--(BUSINESS WIRE)--United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today reported unaudited net sales for the month of September 2026. Revenues for September 2026 Period 2026 2025 Y/Y Change Y/Y (%) September 25,350,431 19,927,175 5,423,256 27.22% Jan.-Sep. 204,009,681 175,743,654 28,266,027 16.08% (*) All figures in thousands of New Taiwan Dollars (NT$), except for percentages. (**) All figures are consolidated Additional information about UMC is available on...
Oct 5, 2026 at 7:00 AM

InTest Expects Record Orders for Q3 2026 and Revenue at High End of Guidance Range for Q3 and Full Year 2026

MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include Semiconductor, Automotive/EV, Defense/Aerospace, Industrial, Life Sciences, and Safety/Security, today announced estimated revenue and orders, for the quarterly period ended September 30, 2026, and estimated backlog at September 30, 2026, based on a review of its preliminary fin...
Oct 1, 2026 at 4:47 PM

SITE Centers Announces Sale of The Maxwell

BEACHWOOD, Ohio--(BUSINESS WIRE)--SITE Centers Announces Sale of The Maxwell...
Oct 1, 2026 at 12:00 PM

ABL Texcell Diagnostics Raises Its 2026 Revenue Guidance to €13.5 Million - €14.0 Million

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Texcell Diagnostics (Euronext Paris: ABLD – ISIN: FR001400AHX6) (the “Company”), a company specializing in molecular diagnostic solutions, healthcare software and services supporting clinical research, s raising its revenue guidance for the financial year ending 31 December 2026. Based on the commercial, operational and accounting information available as of the date of this press release, the Company now expects revenue to be between €13.5...
Sep 30, 2026 at 12:45 PM

Kaleon S.p.A.: Board of Directors Approves the Consolidated Half-Year Financial Report as at 30 June 2026

MILAN--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Kaleon S.p.A. (“Kaleon” or the “Company”) (Paris:ALKLN) (MIL:KLN), a company linked to the Borromeo family and specializing in the management and enhancement of significant artistic, natural, and museum heritage for tourism purposes, listed on Euronext Growth Milan (Ticker: KLN) and on Euronext Growth Paris (Ticker: ALKLN), has approved the consolidated half-year financial report as of June 30, 2026, prepared in accordance with...
Sep 29, 2026 at 12:00 PM

MaaT Pharma Publishes its Half-Year 2026 Results and Provides a Business Update

LYON, France--(BUSINESS WIRE)--MaaT Pharma Publishes its Half-Year 2026 Results and Provides a Business Update...
Turn Your News Into Headlines!
Submit Your Release

Get Story Ideas Delivered to Your Inbox

Sign Up